Feline immunodeficiency virus: A concise review

Frontiers in Bioscience

Volumn 9, Issue , 2004, Pages 370-377

  Kanzaki, Luis Isamu Barros ^a   Looney, David J ^b,c,d  

^a FEDERAL UNIVERSITY OF AMAPÁ   (Brazil)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Animal models; Feline Immunodeficiency Virus; Human Immunodeficiency Virus; Lentivirus; Review; Vaccine

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CAT DISEASE; CLINICAL FEATURE; DISEASE COURSE; FELINE IMMUNODEFICIENCY VIRUS; GENE THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOLOGY; MOLECULAR EVOLUTION; NONHUMAN; REVIEW; VIRUS INFECTION; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS VECTOR; ANIMAL; CAT; CHEMISTRY; DISEASE CARRIER; DISEASE TRANSMISSION; GENETICS; IMMUNOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALIA; FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; FELIS CATUS; HUMAN IMMUNODEFICIENCY VIRUS; LENTIVIRUS; PRIMATES; VERTEBRATA;

ANIMALS; CAT DISEASES; CATS; DISEASE VECTORS; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; IMMUNODEFICIENCY VIRUS, FELINE; VIRAL VACCINES; VIRUS REPLICATION;

EID: 2542441562     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1235     Document Type: Review

References (70)

1. Pedersen NC, E.W. Ho, M.L. Brown & J.K. Yamamoto: Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235, 790-793 (1987)
2. Shelton GH, C.K. Grant, S.M. Colter, M.B. Gardner, W.D. Hardy & R.F. Digiacomo: Feline immunodeficiency virus and feline leukemia virus infection and their relationships to lymphoid malignancies in cats: a retrospective study (1968-1988). J Acquired Immun Defic Synd. 3, 623-630 (1990)
3. Furuya T, Y. Kawaguchi, T. Miyazawa, Y. Fujikawa, Y. Tohya, M. Azetaka, E. Takahashi & T. Mikamia: Existence of feline immunodeficiency virus infection in Jajpanese cat population since 1968. Jpn J Vet Sci 52, 891-893 (1990)
4. Yamamoto JK, E. Sparger, E.W. Ho, P.R. Anderson, P. O'Connor, C.P. Mandell, L. Lowestine, R. Munn & N.C. Pedersen: The pathogenesis of experimentally induced feline induced feline immunodeficiency virus (FIV) infection in cats. Am J Vet Res 49, 1246-1258 (1988)
5. Miyazawa T, K. Tomonaga, Y. Kawaguchi & T. Mikami: The genome of feline immunodeficiency virus. Arch Virol 134, 221-234 (1994)
6. Poeschla EM, F. Wong-Staal & D.J. Looney: Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nat Med 4, 354-357 (1998)
7. Bendinelli M, M. Pistello, S. Lombardi, A. Poll, C. Garzelli, D. Matteucci, L. Ceccherini-Nelli, G. Malvaldi & F. Tozzini: Feline Immunodeficiency Virus: an interesting model for AIDS studies and an important cat pathogen. Clin Microbiol Rev 8, 87-112 (1995)
8. Djalilian HR, Y. Tsuboi, M. Ozeki, M. Tekin, A.R. Djalilian, W. Obritch & J. Lin: Feline immunodeficiency vírus-mediated gene therapy of middle ear mucosa cells. Auris Nasus Larynx 29, 183-186 (2002)
9. Loewen N, M.P. Fautsch, M. Peretz, C.K. Bahler, J.D. Cameron, D.H. Johnson & E.M. Poeschla:. Genetic modification of human trabecular meshwork with lentiviral vectors. Hum Gene Ther 12, 2109-2119 (2001)
10. Stein CS, Y. Kang, S.L. Sauter, K. Townsend, P. Staber, T.A. Derksen, I. Martins, J. Qian, B.L. Davidson & P.B. McCray Jr. In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using nonprimate lentiviral vectors. Mol Ther 3, 850-856 (2001)
11. Brooks AI, C.S. Stein, S.M. Hughes, J. Heth, P.M. McCray Jr., S.L. Sauter, J.C. Johnston, D.A. Cory-Slechta, H.J. Federoff & B.L. Davidson: Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors. Proc Natl Acad Sci USA 99, 5760-5762 (2002)
12. Miyazawa T, T. Furuya, S. Itagaki, Y. Tohya, K. Nakano, E. Takahashi & T. Mikami: Preliminary comparisons of the biological properties of two strains of feline immunodeficiency virus (FIV) isolated in Japan with FIV Petaluma strain isolated in the United States. Arch Virol 108, 59-68 (1989)
13. Philips TR, C. Vamont, D. Konings, B. Shacklett, C. Hamson, P. Luciw & J.H. Elder: Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus. J Virol 66, 5464-5471 (1992)
14. Tomonaga K & T. Mikami. Molecular biology of the feline immunodeficiency virusauxiliary genes. J Gen Virol 77, 1611-1621 (1996)
15. DeParseval A & J.H. Elder: Demonstration that orf2 Encodes the Feline Immunodeficiency Virus Transactivating (Tat) Protein and Characterization of a Unique Gene Product with Partial Rev Activity. J Virol 73, 608-617 (1998)
16. Briquet S, J. Richardson, C. Vanhée-Brossollet & C. Vaquero: Natural antisense transcripts are detected in different cell lines and tissues of cats infected with feline immunodeficiency virus. Gene 267, 157-164 (2001)
17. Tye BK, P.O. Nyman, I.R. Lehman, S. Hochmanhauser & B. Weiss: Transient accumulation of Okazaki fragments as a result of uracil incorporation into nascent DNA. Proc Natl Acad Sci USA 74, 154-157 (1977)
18. Pancino G, I. Fossati, C. Chappey, S. Castelot, B. Hutrel, A. Moraillon, D. Klatzmann & P. Sonigo: Structure and variation of feline immunodeficiency virus envelope glycoproteins. J Virol 67, 664-672 (1993)
19. Manrique ML, C.C.P. Celma, S.A. Gonzalez & J.L. Affranchino: Mutational analysis of the feline immunodeficiency virus matrix protein. Virus Res 76, 103-113 (2001)
20. Nath MD & D.L. Peterson: In vitro assembly of feline immunodeficiency virus capsid protein: Biological role of conserved cysteines. Arch Bioch Biophys 392, 287-294 (2001)
21. Lin Y-C, Z. Beck, T. Lee, V-D. Le, G.M. Morris, A.J. Olson, C-H. Wong & J.H. Elder: Alteration of substrate and inhibitor specificity of feline Immunodeficiency virus protease. J Virol 10, 4710-4720 (2000)
22. Oberste MS & M.A. Gonda: Conservation of amino-acid sequence motifs in lentivirus Vif proteins. Virus Genes 6, 95-102 (1992)
23. Fujita M, A. Sakurai, A. Yoshida, S. Matsumoto, M. Miyaura & A. Adachi: Subtle mutations in the cysteine region of HIV-1 Vif drastically alter the viral replication phenotype. Microbes Infect 4, 621-624 (2002)
24. Chatterji U, C.K. Grant & J.H. Elder: Feline Immunodeficiency Virus vif localizes to the nucleus. J Virol 74, 2533-2540 (2000)
25. Borman A M, C. Quillent, P. Charneau, C. Dauguet & F. Clavel: Human immunodeficiency virus type I Vif-mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity. J Virol 69, 2058-2067 (1995)
26. Zimmerman C, K.C. Klein, P.K. Kiser, A.R. Singh, B.L. Firestein, S.C. Riba & J.R. Lingappa.: Identification of a host protein essential for assembly of immature HIV-1 capsids. Nature 415, 88-92 (2002)
27. Sheehy AM, N.C. Gaddis, J.D. Choi & M.H. Malim: Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature-418, 646-650 (2002)
28. Courchamp F & D. Pontier: Feline immunodeficiency virus: an epidemiological review. C R Acad Sci III 317, 1123-1134 (1994)
29. Carpenter MA, E.W. Brown, D.W. MacDonald & S.J. Obrien: Phylogeographic patterns of feline immunodeficiency virus genetic diversity in the domestic cat. Virology 251, 234-243 (1998)
30. Ishida T, T. Washizu, K. Toriyabe, S. Motoyoshi, I. Tomoda & N.C. Pedersen: Feline immunodeficiency virus infection in cats of Japan. J Am Vet Med Assoc 194, 221-225 (1989)
31. Hartmann K: Feline immunodeficiency virus infection: an overview. Vet J 155, 123-137 (1999)
32. Jordan H L, J.G. Howard, J.G. Bucci, J.L. Butterworth, R. English, S. Kennedy-Stoskopf, M.B. Tompkins & W.A. Tompkins: Horizontal transmission of feline immunodeficiency virus with semen from seropositive cats. J Reprod Immunol 41, 341-357 (1998)
33. Rogers AB & E.A. Hoover: Maternal-fetal feline immunodeficiency virus transmission: timing and tissue tropisms. J Infect Dis 178, 960-967 (1998)
34. O'Neil LL, M.J. Burkhard, L.J. Diehl & E.A. Hoover: Vertical transmission of feline immunodeficiency virus. AIDS Res Hum Retroviruses 1, 171-182 (1995)
35. Sellon RK, H.L. Jordan, S. Kennedy-Stoskopf, M.B. Tompkins & W.A. Tompkins: Feline immunodeficiency virus can be experimentally transmitted via milk during acute maternal infection. J Virol 68, 3380-3385 (1994)
36. Bachmann MH, C. Mathiason-Dubard, G.H. Learn, A.G. Rodrigo, D.L. Sodora, P. Mazzeti, E.A. Hoover & J.I. Mullins: Genetic diversity of feline immunodeficiency virus: Dual infection, recombination and distinct evolutionary rates. J Virol 71, 4241-4253 (1997)
37. Willet BJ, M.J. Hosie, A.R.E Shaw & J.C. Neil: Inhibition of feline immunodeficiency virus infection by CD9 antibody operates after viral entry and is independent of virus tropism. J Gen Virol 78, 611-618 (1997)
38. Bisset LR, H. Lutz, J. Boni, R. Hofmann-Lehmann, R. Luthy, J. Schupbach: Combined effect of zidovudine (ZDV), lamivudine (3TC) and abacavir (ABC) antiretroviral therapy in suppressing in vitro FIV replication. Antiviral Research 53, 35-45 (2002)
39. McCaw D: Caring for the retrovirus infected cat. Semin Vet Med Surg 10, 216-219 (1995)
40. Kathleen AH, A.J. Phipps & S. Francke: Antiviral therapy reduces viral burden but does not prevent thymic involution in young cats infected with Feline Immunodeficiency Virus. Antimicrob Agents Chemother 44, 2399-2405 (2000)
41. Dow SW, M.L. Poss & E.A. Hoover: Feline immunodeficiency virus: a neurotropic lentivirus. J Acquir Immun Defic Syndr 3, 658-668 (1990)
42. Willet B J, M.J. Hosie, O. Jarret & J.N. Neil: Identification of a putative cellular receptor for feline immunodeficiency virus as the feline homologue of CD9. Immunology 81, 228-233 (1994)
43. Frey SCS, E.A. Hoover & J.I. Mullins: Feline Immunodeficiency Virus Cell Entry. J Virol 75, 5433-5440 (2001)
44. DeParseval A & J.H. Elder: Binding of recombinant Feline Immunodeficiency Virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor. J Virol 75, 4528-4539 (2001)
45. Saphire ACS, M.D. Bobardt, Z. Zhang, G. David, P.A. Gallay: Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages. J Virol 75, 9187-9200 (2001)
46. Poeschla EM & D.J. Looney: CXCR4 Is required by a nonprimate lentivirus: heterologous expression of Feline Immunodeficiency Virus in human, rodent, and feline cells. J Virol 72, 6858-6866 (1998)
47. + T lymphocytes. J Virol 65, 3359-3364 (1991)
48. Brunner D & N.C. Pedersen: Infection of peritoneal macrophages in vitro and in vivo with feline immunodeficiency virus. J Virol 63, 5483-5488 (1989)
49. Hein A, J.P. Martin & R. Dörries: In vitro activation of feline immunodeficiency virus in ramified microglial cells from asymptomatically infected cats. J Virol 75, 8090-8095 (2001)
50. Cara A & M.S. Reitz Jr.: New insight on the role of extrachromosomal retroviral DNA. Leukemia 11, 1395-1399 (1997)
51. Teo L, C. Veryard, H. Barnes, S.F. An, M. Jones, P.L. Lantos, P. Luthert & S. Shaunak: Circular forms of unintegrated human immunodeficiency virus type 1 DNA and high levels of viral protein expression: association with dementia and multinucleated giant cells in the brain of patients with AIDS. J Virol 71, 2928-2933 (1997)
52. Browning MT, R.D. Schmidt, K.A. Lew & T.A. Rizvi: Primate and feline lentivirus vector RNA packaging and propagation by heterologous lentivirus virions. J Virol 75, 5129-5140 (2001)
53. Morris KV, C. Barroga, W. Witke, O. Marjanovic, C. Chung, L. Innis, J. Gilbert, M. Gasmi, F. Wong-Staal & D.J. Looney: Transduction of Cell Lines and Primary Cells by FIV Packaged HIV Vectors. J Virol submitted (2003)
54. Johnston JB & C. Power: Feline immunodeficiency virus xenoinfection: the role of chemokine receptors and envelope diversity. J Virol 76, 3626-3636 (2002)
55. Curran MA & GP Nolan: Nonprimate lentiviral vectors. Curr Top Microbiol Immunol 261, 75-105 (2002)
56. Loewen N, C. Bahler, W.L. Teo, T. Whitwam, M. Peretz, R. Xu, M.P. Fautsch, D.H. Johnson & E.M. Poeschla: Preservation of aqueous outflow facility after second-generation FIV vector-mediated expression of marker genes in anterior segments of human eyes. Invest Ophthalmol Vis Sci 43, 3686-3690 (2002)
57. Kemler I, R. Barraza & E.M. Poeschla: Mapping the encapsidation determinants of feline immunodeficiency virus. J Virol 76, 11889-11903 (2002)
58. Price MA, S.S. Case, D.A. Carbonaro, X.J. Yu, D. Petersen, K.M. Sabo, M.A. Curran, B.C. Engel, H. Margarian, J.L. Abkowitz, G.P. Nolan, D.B. Kohri & G.M. Crooks: Expression from second-generation feline immunodeficiency virus vectors is impaired in human hematopoietic cells. Mol Ther 6, 645-652 (2002).
59. Tompkins MB, M.E. Bull, J.L. Dow, J.M. Ball, E.W. Collisson, B.J. Winslow, A.P. Phadke, T.W. Vahlenkamp & W.A. Tompkins: Feline immunodeficiency virus infection is characterized by B7+CTLA4+ T cell apoptosis. J Infect Dis 185, 1077-1093 (2002)
60. Johnson CM, G.P. Papadi, W.A. Tompkins, R.K. Sellon, M.S. Orandle, J.R. Bellah & L.J. Bubenik. Biphasic thymus response by kittens inoculated with feline immunodeficiency virus during fetal development. Vet Pathol 35, 191-201 (1998)
61. Willett BJ & M.J. Hoxie: The role of the chemokine receptor CXCR4 in infection with feline immunodeficiency virus. Mol Membr Biol 16, 67-72 (1999)
62. Johnston J, C. Silva, T. Hiebert, R. Buist, M. Dawood, J. Peeling & C. Power: Neurovirulence depends on virus input titer in brain in feline immunodeficiency virus infection: Evidence for activation of innate immunity and neuronal injury. J Neurovirol 8, 420-431 (2002)
63. Clements JE & M.C. Zink: Molecular biology and pathogenesis of animal lentivirus infections. Clin Microbiol Reviews 9, 100-117 (1996)
64. Dow SW, M.L. Poss & E.A. Hoover: Feline immunodeficiency virus: a neurotropic lentivirus. J Acquir Immun Defic Syndr 3, 658-668 (1990)
65. Sanders VJ, C.A. Wiley & R.L. Hamilton: The mechanisms of neuronal damage in retroviral infections of the nervous system. Curr Top Microbiol Immunol 253, 179-201 (2001)
66. VandWoude S, C.A. Hageman, S.J. O'Brien & E.A. Hoover: Nonpathogenic lion and puma lentiviruses impart resistance to superinfection by virulent feline immunodeficiency virus. J Acquir Immun Defic Syndr 29, 1-10 (2002)
67. Bigornia L, K.M. Lockridge & E.E. Sparger: Construction and in vitro characterization of attenuated feline immunodeficiency virus long terminal repeat mutant viruses. J Virol 75, 1054-1060 (2001)
68. Finerty S, C.R. Stokes, T.J. Gruffyd-Jones, T.J. Hillman, F.J. Barr & D.A. Harbour: Targeted lymph node immunization can protect cats from a mucosal challenge with feline immunodeficiency virus. Vaccine 20, 49-58 (2002)
69. Lockridge KM, M. Chien, G.A. Dean, K.S. Cole, R.C. Montelaro & P.A. Luciw, EE Sparger. Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted pro viral DNA. Virology 273, 67-69 (2000)
70. Pu R, J. Coleman, M. Omori, M. Arai, T. Hohdatsu, C. Huang, T. Tanabe & J.K. Yamamoto: Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous subtype FIV isolates. AIDS 15, 1225-1237 (2001)